---
figid: PMC8000049__ijms-22-02871-g008
figtitle: Cycle of ISG15
organisms:
- Human immunodeficiency virus 1
- Human immunodeficiency virus
- Mouse mammary tumor virus
- Human T-cell leukemia virus type I
- Moloney murine leukemia virus
- Simian immunodeficiency virus
- Murine leukemia virus
- Rous sarcoma virus
- Avian retrovirus
- Human endogenous retrovirus K
- Avian sarcoma virus
- Equine infectious anemia virus
- Mason-Pfizer monkey virus
- Bovine leukemia virus
- Human spumaretrovirus
- Human foamy virus
- Homo sapiens
- Mus musculus
- Saccharomyces cerevisiae
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8000049
filename: ijms-22-02871-g008.jpg
figlink: pmc/articles/PMC8000049/figure/ijms-22-02871-f008/
number: F8
caption: The cycle of ISG15. Viral infection induces the expression of type I IFN.
  These molecules activate the JAK/STAT signaling pathway, which is responsible for
  the activation of the ISG15 promoter (for reviews see [,]). The ISG15 is maturated
  by ISG15-specific proteases which cleave the C-terminal extension from ISG15 precursor.
  (1) The mature ISG15 is activated by UBE1L (E1). It corresponds to the formation
  of a thioester bond between ISG15 and E1. (2) ISG15 linked to UBE1L is transferred
  to UbcH8 (E2). (3) Finally, E2 recruits an E3 ligase such as HERC5, transferring
  the activated Ub from the E2 to the K substrate (ligation reaction). (4) The reaction
  can be reverted via UBP43. Indeed, it cleaves ISG15 molecules that are conjugated
  to the substrate proteins via isopeptide bonds (adapted from []).
papertitle: 'Post-Translational Modifications of Retroviral HIV-1 Gag Precursors:
  An Overview of Their Biological Role.'
reftext: Charlotte Bussienne, et al. Int J Mol Sci. 2021 Mar;22(6):2871.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.881912
figid_alias: PMC8000049__F8
figtype: Figure
redirect_from: /figures/PMC8000049__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8000049__ijms-22-02871-g008.html
  '@type': Dataset
  description: The cycle of ISG15. Viral infection induces the expression of type
    I IFN. These molecules activate the JAK/STAT signaling pathway, which is responsible
    for the activation of the ISG15 promoter (for reviews see [,]). The ISG15 is maturated
    by ISG15-specific proteases which cleave the C-terminal extension from ISG15 precursor.
    (1) The mature ISG15 is activated by UBE1L (E1). It corresponds to the formation
    of a thioester bond between ISG15 and E1. (2) ISG15 linked to UBE1L is transferred
    to UbcH8 (E2). (3) Finally, E2 recruits an E3 ligase such as HERC5, transferring
    the activated Ub from the E2 to the K substrate (ligation reaction). (4) The reaction
    can be reverted via UBP43. Indeed, it cleaves ISG15 molecules that are conjugated
    to the substrate proteins via isopeptide bonds (adapted from []).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFNA1
  - ISG15
  - ERVK-8
  - ERVK-10
  - ERVK-9
  - ERVK-21
  - ERVK-18
  - ERVK-25
  - ERVK-24
  - ERVK-19
  - ATP8A2
  - UBA7
  - USP18
  - UBE2E2
  - UBE2L6
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - Sh
  - ATPsynbeta
  - Atpalpha
  - Stat92E
  - hop
  - bsk
  - SH
  - ATP
  - AMP
  - (E3)-SH
  - viral infection
---
